Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Clinical characteristics and outcomes of HIV-associated immune complex kidney disease.

Booth JW, Hamzah L, Jose S, Horsfield C, O'Donnell P, McAdoo S, Kumar EA, Turner-Stokes T, Khatib N, Das P, Naftalin C, Mackie N, Kingdon E, Williams D, Hendry BM, Sabin C, Jones R, Levy J, Hilton R, Connolly J, Post FA; HIV/CKD Study and the UK CHIC Study.

Nephrol Dial Transplant. 2016 Jan 18. pii: gfv436. [Epub ahead of print]

PMID:
26786550
2.

Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.

Huntington SF, Weiss BM, Vogl DT, Cohen AD, Garfall AL, Mangan PA, Doshi JA, Stadtmauer EA.

Lancet Haematol. 2015 Oct;2(10):e408-16. doi: 10.1016/S2352-3026(15)00151-9. Epub 2015 Sep 17.

PMID:
26686042
3.

The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy.

Huntington S, Thorne C, Newell ML, Anderson J, Taylor GP, Pillay D, Hill T, Tookey PA, Sabin C; UK Collaborative HIV Cohort (UK CHIC) Study and the UK and Ireland National Study of HIV in Pregnancy and Childhood (NSHPC).

AIDS. 2015 Nov;29(17):2269-78. doi: 10.1097/QAD.0000000000000826.

4.

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation.

Jose S, Quinn K, Dunn D, Cox A, Sabin C, Fidler S; UK CHIC and UK HDRD Steering Committees.

HIV Med. 2015 Aug 25. doi: 10.1111/hiv.12302. [Epub ahead of print]

PMID:
26306942
5.

Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells.

Evans AG, Rothberg PG, Burack WR, Huntington SF, Porter DL, Friedberg JW, Liesveld JL.

Br J Haematol. 2015 Jun 18. doi: 10.1111/bjh.13562. [Epub ahead of print]

PMID:
26084925
6.

Cost-effectiveness analysis of routine surveillance imaging of patients with diffuse large B-cell lymphoma in first remission.

Huntington SF, Svoboda J, Doshi JA.

J Clin Oncol. 2015 May 1;33(13):1467-74. doi: 10.1200/JCO.2014.58.5729. Epub 2015 Mar 30.

PMID:
25823735
7.

Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy.

Huntington S, Thorne C, Newell ML, Anderson J, Taylor GP, Pillay D, Hill T, Tookey PA, Sabin C; UK Collaborative HIV Cohort (UK CHIC) Study; UK and Ireland National Study of HIV in Pregnancy and Childhood (NSHPC).

AIDS. 2015 Apr 24;29(7):801-9. doi: 10.1097/QAD.0000000000000620.

8.

Utility of interim and end-of-treatment [(18)F]-fluorodeoxyglucose positron emission tomography-computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma.

Huntington SF, Nasta SD, Schuster SJ, Doshi JA, Svoboda J.

Leuk Lymphoma. 2015;56(9):2579-84. doi: 10.3109/10428194.2015.1007506. Epub 2015 Feb 11.

PMID:
25629993
9.

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.

HIV-CAUSAL Collaboration, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA.

Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6.

PMID:
25567330
10.

Symptomatic Exposures Among California Inmates 2011-2013.

Butterfield M, Al-Abri S, Huntington S, Carlson T, Geller RJ, Olson KR.

J Med Toxicol. 2015 Sep;11(3):309-16. doi: 10.1007/s13181-014-0456-6.

PMID:
25526949
11.

Does pregnancy increase the risk of ART-induced hepatotoxicity among HIV-positive women?

Huntington S, Thorne C, Anderson J, Newell ML, Taylor G, Pillay D, Hill T, Tookey P, Sabin C.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19486. doi: 10.7448/IAS.17.4.19486. eCollection 2014.

12.

Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women.

Huntington S, Thorne C, Anderson J, Newell ML, Taylor GP, Pillay D, Hill T, Tookey P, Sabin C; UK Collaborative HIV Cohort (UK CHIC) Study; National Study of HIV in Pregnancy and Childhood (NSHPC).

BMC Infect Dis. 2014 Mar 4;14:127. doi: 10.1186/1471-2334-14-127.

13.

Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure.

Jose S, Hamzah L, Campbell LJ, Hill T, Fisher M, Leen C, Gilson R, Walsh J, Nelson M, Hay P, Johnson M, Chadwick D, Nitsch D, Jones R, Sabin CA, Post FA; UK Collaborative HIV Cohort Study Steering Committee.

J Infect Dis. 2014 Aug 1;210(3):363-73. doi: 10.1093/infdis/jiu107. Epub 2014 Feb 28.

14.

Serious adverse effects from single-use detergent sacs: report from a U.S. statewide poison control system.

Huntington S, Heppner J, Vohra R, Mallios R, Geller RJ.

Clin Toxicol (Phila). 2014 Mar;52(3):220-5. doi: 10.3109/15563650.2014.892122.

PMID:
24580062
15.

Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppression.

O'Connor JL, Smith CJ, Lampe FC, Hill T, Gompels M, Hay P, Chadwick D, Fisher M, Ainsworth J, Gilson R, Mackie N, Anderson J, Orkin C, Nelson M, Kegg S, Leen C, Palfreeman A, Post F, Johnson M, Sabin CA, Phillips AN; UK Collaborative HIV Cohort (UK CHIC) Study Steering Committee.

AIDS. 2014 Mar 27;28(6):919-24. doi: 10.1097/QAD.0000000000000165.

PMID:
24335482
16.

The effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrations.

Samuel M, Jose S, Winston A, Nelson M, Johnson M, Chadwick D, Fisher M, Leen C, Gompels M, Gilson R, Post FA, Hay P, Sabin CA; UK Collaborative HIV Cohort Study.

HIV Med. 2014 May;15(5):311-6. doi: 10.1111/hiv.12103. Epub 2013 Nov 19.

17.

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults.

Mackie NE, Dunn DT, Dolling D, Garvey L, Harrison L, Fearnhill E, Tilston P, Sabin C, Geretti AM; UK HIV Drug Resistance Database; UK CHIC study.

AIDS. 2013 Sep 10;27(14):2245-53. doi: 10.1097/QAD.0b013e3283636179.

PMID:
24157905
18.

HLA B*5701 status, disease progression, and response to antiretroviral therapy.

UK Collaborative HIV Cohort Study Steering Committee.

AIDS. 2013 Oct 23;27(16):2587-92. doi: 10.1097/01.aids.0000432613.95455.71.

19.

Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study.

Dolling DI, Dunn DT, Sutherland KA, Pillay D, Mbisa JL, Parry CM, Post FA, Sabin CA, Cane PA; UK HIV Drug Resistance Database (UKHDRD); UK Collaborative HIV Cohort Study (UK CHIC).

J Antimicrob Chemother. 2013 Oct;68(10):2339-43. doi: 10.1093/jac/dkt199. Epub 2013 May 27.

20.

Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring.

Winston A, Jose S, Gibbons S, Back D, Stohr W, Post F, Fisher M, Gazzard B, Nelson M, Gilson R, Orkin C, Johnson M, Palfreeman A, Chadwick D, Leen C, Schwenk A, Anderson J, Gompels M, Dunn D, Khoo S, Sabin C; UK Collaborative HIV Cohort Study.

J Antimicrob Chemother. 2013 Jun;68(6):1354-9. doi: 10.1093/jac/dkt029. Epub 2013 Feb 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk